Results 191 to 200 of about 35,241 (222)

Stress, plasticity, and fibrosis: unfolding the role of the IRE1α/RIDD/Fgfr2 axis. [PDF]

J Clin Invest
Han S.
europepmc   +1 more source

Fusion oncoproteins orchestrate tumorigenesis and sustain malignant progression via a positive feedback mechanism. [PDF]

Cell Biosci
Ying W, Wang X, Yu J, Wang J, He Q, Yang B, Chen Y, Ying M.   +7 more
europepmc   +1 more source

FGF9-FGFR2 Signaling via Osteocytes-Preosteoblasts Crosstalks to Mediate Mechanotransduction-Driven Intramembranous Osteogenesis in the Underdeveloped Maxilla. [PDF]

Adv Sci (Weinh)
Zhou Y, Chen L, Han M, Zhu P, Wang Y, Yu X, Reng T, Wang H, Li B, Zhang C, Huang Z, Lin S, Wang G, Ge J, Guo B, Li H.   +15 more
europepmc   +1 more source

Tasurgratinib (E7090) for cholangiocarcinoma with fibroblast growth factor receptor 2 fusions/rearrangements: a multicenter, open-label, Phase 2 study. [PDF]

Jpn J Clin Oncol
Shen L, Duan H, Kuwahara T, Satoh T, Ma X, Yan S, Zhao H, Ikeda M, Cui T, Sasaki T, Meng Z, Nakai Y, Ueno M, Komatsu Y, Nagano H, Morizane C, Funasaka S, Ikezawa H, Nakada T, Furuse J.   +19 more
europepmc   +1 more source

Expanding Horizons in Cholangiocarcinoma: Emerging Targets Beyond FGFR2 and IDH1. [PDF]

Int J Mol Sci
Darman L, Kaurich Q, Hassan MS, von Holzen U, Awasthi N.   +4 more
europepmc   +1 more source

Genetic risk score for cholesteatoma recurrence: using UK Biobank data toward more individualized patient management. [PDF]

Int J Mol Epidemiol Genet
Vlastos IM, Mohannad A, Hajiioannou J, Chronopoulou T, Peng H, Gkouskou K.   +5 more
europepmc   +1 more source

Mettl1-mediated m⁷G modification of Fgfr2 regulates osteogenic and chondrogenic differentiation of mesenchymal stem cells. [PDF]

Int J Biol Sci
Li Q, Zhang Y, Ji P, Zhang Y, Jiang J, Jin J, Yuan Z, Tian G, Cai M, Feng P, Wu Y, Liu W, Wang P.   +12 more
europepmc   +1 more source

Illuminating the FGFR fusion landscape in Chinese patients: unveiling novel molecular insights and clinical implications. [PDF]

Oncologist
Liu Z, Zhao D, Wang B, Qian Z, Liu Z, Yang Q, Tao J, Shao Y, Lv M, Zhang Y, Zhu J, Zhang J, Li W, Wang X, Wang C, Ma T, Zhu Y.   +16 more
europepmc   +1 more source

FGFR2 identified as a NETs-associated biomarker and therapeutic target in diabetic foot ulcers. [PDF]

Eur J Med Res
Dai L, Rui S, Yang M, Yu S, Chen Q, Wang H, Deng B, Deng L, Hao W, Wu X, Armstrong DG, Cao Z, Duan X, Deng W.   +13 more
europepmc   +1 more source

Clinical Significance of Extrachromosomal DNA in <i>FGFR2</i>-Amplified Gastric Cancer: Therapeutic Implications From Clinical Experience. [PDF]

JCO Precis Oncol
Aoki Y, Hashimoto T, Takahashi N, Okunaka M, Mishima S, Kotani D, Kawazoe A, Nakamura Y, Nakayama I, Kuboki Y, Bando H, Kojima T, Nakamura N, Sakamoto N, Ishii G, Fujisawa T, Yoshino T, Arai Y, Shibata T, Shitara K.   +19 more
europepmc   +1 more source